Sep 28, 2021 09:06 PM (GMT+8) · EqualOcean
Financial Associated Press, September 28 - Rhine biology announced that today, the company received the notification letter on reducing the company's shares by more than 1% through block trading and the simplified equity change report issued by Yao Xinde, a shareholder and director holding more than 5% of the company, and learned that due to its own capital needs, On September 28, 2021, 6102800 shares of the company were reduced through the block trading system of Shenzhen Stock Exchange, accounting for 1.07973% of the capital stock of the head office.

This text is a result of machine translation.